URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Pradyumna Phatak

Concepts (240)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Hemochromatosis
20
1994
39
5.870
Why?
Iron Chelating Agents
7
2007
10
2.730
Why?
Iron Overload
8
2000
11
2.560
Why?
Benzoates
4
2007
14
2.350
Why?
Triazoles
4
2007
37
2.300
Why?
Histocompatibility Antigens Class I
7
1997
95
1.960
Why?
Membrane Proteins
7
1997
540
1.740
Why?
Blood Transfusion
4
2007
171
0.890
Why?
Ferritins
9
1994
52
0.880
Why?
Mass Screening
6
1994
247
0.870
Why?
Iron
7
1994
147
0.830
Why?
Drug-Induced Liver Injury
1
2011
36
0.790
Why?
Point Mutation
3
1997
172
0.760
Why?
Bone Marrow Diseases
1
2009
43
0.650
Why?
Sex Chromosome Aberrations
1
2008
8
0.630
Why?
Chromosomes, Human, X
1
2008
11
0.620
Why?
Leukemia, Myeloid, Acute
2
1999
177
0.620
Why?
Genetic Testing
1
2008
96
0.610
Why?
Middle Aged
24
1989
9837
0.600
Why?
Thalassemia
3
1997
23
0.600
Why?
Myelodysplastic Syndromes
1
2009
131
0.580
Why?
Humans
46
1988
36274
0.580
Why?
Homozygote
6
1996
97
0.560
Why?
Genotype
7
1997
490
0.550
Why?
Mutation, Missense
3
2002
87
0.550
Why?
Lung Diseases, Interstitial
1
2005
10
0.510
Why?
Actins
6
1988
192
0.510
Why?
Liver
7
1994
877
0.500
Why?
Adult
23
1994
11351
0.500
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2005
55
0.490
Why?
Transferrin
6
1994
38
0.490
Why?
Pyrimidines
1
2005
64
0.480
Why?
Piperazines
1
2005
74
0.480
Why?
Female
23
1994
19838
0.460
Why?
HLA Antigens
3
1996
99
0.440
Why?
Anemia
2
1997
78
0.440
Why?
Male
25
1989
19675
0.410
Why?
Aged
12
1994
7269
0.390
Why?
Cost-Benefit Analysis
4
1994
215
0.390
Why?
Osteoarthritis
1
2003
148
0.390
Why?
Administration, Oral
3
2007
308
0.380
Why?
Lymphoma
2
1997
162
0.350
Why?
Antineoplastic Agents
1
2005
619
0.340
Why?
Prevalence
5
1994
562
0.330
Why?
Corynebacterium Infections
1
1998
8
0.330
Why?
Parvoviridae Infections
1
1998
11
0.330
Why?
Infectious Mononucleosis
1
1998
21
0.330
Why?
Phenotype
5
1997
763
0.320
Why?
Dose-Response Relationship, Drug
3
1996
1117
0.320
Why?
Immunoblastic Lymphadenopathy
1
1997
5
0.300
Why?
Giant Lymph Node Hyperplasia
1
1997
5
0.300
Why?
Sarcoidosis
1
1997
31
0.290
Why?
Cation Transport Proteins
2
2005
22
0.290
Why?
Anemia, Sideroblastic
1
1997
9
0.290
Why?
Primary Myelofibrosis
1
1997
9
0.290
Why?
Splenectomy
1
1997
35
0.290
Why?
Copper
1
1997
54
0.280
Why?
Burkitt Lymphoma
3
1989
52
0.280
Why?
Diagnosis, Differential
3
1997
874
0.280
Why?
Heterozygote
2
2003
125
0.270
Why?
Lymph Nodes
1
1997
206
0.270
Why?
Liver Cirrhosis
3
2002
71
0.250
Why?
Lymphocyte Activation
1
1997
410
0.250
Why?
Phlebotomy
2
2008
4
0.230
Why?
Receptors, Antigen, T-Cell
1
1994
66
0.230
Why?
Biopsy
4
1994
362
0.220
Why?
Lymphocytes
1
1994
291
0.220
Why?
Translocation, Genetic
2
1994
63
0.210
Why?
Drug Costs
2
2008
25
0.210
Why?
Amino Acid Substitution
2
2005
124
0.210
Why?
Economics, Pharmaceutical
2
2007
6
0.210
Why?
Aged, 80 and over
4
1994
2529
0.210
Why?
Deferoxamine
2
2007
16
0.190
Why?
Mandibular Nerve
1
2011
9
0.190
Why?
Cranial Nerve Diseases
1
2011
10
0.190
Why?
Tretinoin
3
1995
103
0.180
Why?
Creatinine
1
2010
127
0.180
Why?
Safety
1
2010
101
0.180
Why?
Antibodies, Monoclonal
1
1994
711
0.170
Why?
Cross-Sectional Studies
3
1998
654
0.170
Why?
Adolescent
8
1994
4766
0.170
Why?
Antimicrobial Cationic Peptides
1
2009
13
0.170
Why?
Medication Adherence
1
2009
21
0.170
Why?
International Classification of Diseases
1
2009
15
0.160
Why?
Risk Factors
2
2003
2345
0.160
Why?
Erythrocyte Transfusion
1
2009
57
0.160
Why?
von Willebrand Diseases
2
1996
22
0.160
Why?
Early Diagnosis
1
2008
29
0.160
Why?
Mutation
4
1996
1216
0.160
Why?
Chelation Therapy
1
2008
5
0.160
Why?
Treatment Outcome
4
1997
2615
0.160
Why?
Karyotyping
1
2008
109
0.150
Why?
Anemia, Sickle Cell
1
2008
47
0.150
Why?
Protein Kinase C
2
1988
232
0.150
Why?
In Situ Hybridization, Fluorescence
1
2008
110
0.150
Why?
Treatment Refusal
1
2007
43
0.150
Why?
Granulocytes
3
1995
80
0.150
Why?
Quality of Life
2
2000
502
0.140
Why?
Genetic Predisposition to Disease
1
2009
331
0.140
Why?
Randomized Controlled Trials as Topic
1
2009
411
0.140
Why?
Case-Control Studies
1
2009
617
0.140
Why?
Child
7
1994
4155
0.130
Why?
Primary Health Care
2
1998
487
0.130
Why?
Dyspnea
1
2005
13
0.130
Why?
Interleukin-8
3
1993
111
0.130
Why?
Retrospective Studies
2
2008
2267
0.130
Why?
Oxygen Inhalation Therapy
1
2005
49
0.130
Why?
Radiography, Thoracic
1
2005
62
0.130
Why?
T-Lymphocytes
1
1988
550
0.120
Why?
Gene Frequency
2
1996
88
0.120
Why?
DNA Mutational Analysis
2
1996
189
0.110
Why?
Chondrocalcinosis
1
2003
3
0.110
Why?
Australia
1
2002
27
0.110
Why?
Hand
1
2003
71
0.100
Why?
Continental Population Groups
1
2002
121
0.100
Why?
Heart Diseases
1
2002
142
0.090
Why?
Age Factors
2
2000
1128
0.090
Why?
Genitalia, Female
1
2000
22
0.090
Why?
N-Formylmethionine Leucyl-Phenylalanine
3
1993
27
0.090
Why?
Genital Diseases, Female
1
2000
32
0.090
Why?
Family Health
1
2000
90
0.090
Why?
Cohort Studies
2
1997
969
0.090
Why?
Child, Preschool
3
1994
2660
0.090
Why?
Meninges
1
1999
21
0.090
Why?
Statistics, Nonparametric
1
2000
262
0.090
Why?
Multiple Myeloma
1
1999
76
0.080
Why?
Meningeal Neoplasms
1
1999
50
0.080
Why?
Bone Marrow Examination
1
1998
23
0.080
Why?
Blood Cell Count
1
1998
45
0.080
Why?
Leukemia, Promyelocytic, Acute
2
1995
32
0.080
Why?
Feasibility Studies
1
1998
202
0.080
Why?
Heterozygote Detection
1
1997
25
0.070
Why?
Bone Marrow Cells
1
1998
221
0.070
Why?
Brain Neoplasms
1
1999
281
0.070
Why?
von Willebrand Factor
1
1996
59
0.070
Why?
Linkage Disequilibrium
1
1996
18
0.070
Why?
Multiple Endocrine Neoplasia Type 1
1
1996
5
0.070
Why?
Factor VIII
1
1996
50
0.070
Why?
United States
4
1996
2688
0.070
Why?
Purpura, Thrombocytopenic
1
1996
15
0.070
Why?
Infant
2
1994
2278
0.070
Why?
Chemotaxis
1
1996
32
0.070
Why?
Anemia, Iron-Deficiency
1
1996
39
0.070
Why?
Spleen
1
1997
341
0.060
Why?
Phagocytosis
1
1996
85
0.060
Why?
Granulocyte Colony-Stimulating Factor
1
1995
44
0.060
Why?
Chromosome Mapping
1
1996
227
0.060
Why?
Bloodletting
1
1994
1
0.060
Why?
Chromosomes, Human, Pair 6
1
1994
13
0.060
Why?
Dimethyl Sulfoxide
1
1995
47
0.060
Why?
Genes, Recessive
1
1994
38
0.060
Why?
Chromosomes, Human, Pair 14
1
1994
15
0.060
Why?
Chromosomes, Human, Pair 18
1
1994
15
0.060
Why?
Chromosomes, Human, Pair 19
1
1994
14
0.060
Why?
Chromosomes, Human, Pair 1
1
1994
25
0.060
Why?
Dexamethasone
1
1996
181
0.060
Why?
Algorithms
1
1998
541
0.060
Why?
Ionomycin
1
1994
13
0.060
Why?
New York
1
1998
1305
0.060
Why?
Leukemia
1
1995
158
0.060
Why?
Life Expectancy
1
1994
33
0.060
Why?
Patient Selection
1
1996
212
0.060
Why?
Intracellular Membranes
1
1994
74
0.060
Why?
Calcium
3
1993
1083
0.060
Why?
Protein Kinase Inhibitors
1
1994
92
0.060
Why?
Patient Compliance
2
1998
174
0.050
Why?
Predictive Value of Tests
2
1998
606
0.050
Why?
Decision Making
1
1994
223
0.050
Why?
Neutrophils
1
1993
312
0.050
Why?
Lip
1
2011
17
0.050
Why?
Chin
1
2011
12
0.050
Why?
Sensitivity and Specificity
1
1994
905
0.050
Why?
Sphingosine
1
1988
20
0.040
Why?
Epidemiologic Measurements
1
2008
1
0.040
Why?
Cysteine
1
2009
155
0.040
Why?
Tetradecanoylphorbol Acetate
1
1988
149
0.040
Why?
Lymphoma, Follicular
1
1989
54
0.040
Why?
Pyridones
1
2007
11
0.040
Why?
Cell Transformation, Neoplastic
1
1989
137
0.040
Why?
Cardiomyopathies
1
2008
82
0.040
Why?
Fatal Outcome
2
1996
104
0.040
Why?
Protein Conformation
1
1988
299
0.040
Why?
Databases, Factual
1
2008
156
0.040
Why?
beta-Thalassemia
1
2007
7
0.040
Why?
Drug Utilization Review
1
2007
6
0.040
Why?
Ethnic Groups
1
2008
152
0.040
Why?
Insurance Claim Review
1
2007
26
0.040
Why?
Cost of Illness
1
2007
79
0.040
Why?
Markov Chains
1
2007
40
0.040
Why?
Enzyme Activation
1
1988
554
0.030
Why?
Infusions, Intravenous
1
2007
143
0.030
Why?
Drug Administration Schedule
1
2007
366
0.030
Why?
Genes, Dominant
1
2005
79
0.030
Why?
Delivery of Health Care
1
2007
146
0.030
Why?
Pedigree
1
2005
231
0.030
Why?
Signal Transduction
1
1993
1567
0.030
Why?
Alanine Transaminase
1
2003
23
0.030
Why?
Liver Function Tests
1
2003
28
0.030
Why?
Aspartate Aminotransferases
1
2003
38
0.030
Why?
ROC Curve
1
2003
126
0.030
Why?
Regression Analysis
1
2003
527
0.020
Why?
Menstruation
1
2000
16
0.020
Why?
Labor, Obstetric
1
2000
32
0.020
Why?
Logistic Models
1
2003
611
0.020
Why?
Cell Differentiation
2
1995
1093
0.020
Why?
False Positive Reactions
1
1998
88
0.020
Why?
Informed Consent
1
1998
84
0.020
Why?
Education, Medical, Continuing
1
1998
64
0.020
Why?
Radiotherapy
1
1999
198
0.020
Why?
Cerebral Cortex
1
1999
248
0.020
Why?
Ristocetin
1
1996
6
0.020
Why?
Bleeding Time
1
1996
10
0.020
Why?
HL-60 Cells
1
1996
52
0.020
Why?
DNA Probes
1
1996
88
0.020
Why?
L-Selectin
1
1995
15
0.020
Why?
Biological Markers
1
1998
560
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
1999
429
0.020
Why?
Genetic Markers
1
1996
134
0.020
Why?
Questionnaires
1
2000
1004
0.020
Why?
Alleles
1
1996
205
0.020
Why?
Antigens, Surface
1
1995
98
0.020
Why?
Integrins
1
1995
48
0.020
Why?
Dimerization
1
1996
157
0.020
Why?
Immunophenotyping
1
1995
114
0.020
Why?
Nitroblue Tetrazolium
1
1995
4
0.020
Why?
Cell Adhesion Molecules
1
1995
70
0.020
Why?
Pregnancy
1
2000
1966
0.020
Why?
Cell Size
1
1995
88
0.020
Why?
Chemotaxis, Leukocyte
1
1995
29
0.020
Why?
Neoplasm Metastasis
1
1996
228
0.020
Why?
Oxidation-Reduction
1
1995
304
0.010
Why?
Pertussis Toxin
1
1993
52
0.010
Why?
Virulence Factors, Bordetella
1
1993
54
0.010
Why?
Polymerase Chain Reaction
1
1996
596
0.010
Why?
Bone Marrow
1
1994
287
0.010
Why?
Polymers
1
1993
79
0.010
Why?
Tumor Cells, Cultured
1
1995
881
0.010
Why?
Molecular Sequence Data
1
1996
1988
0.010
Why?
Follow-Up Studies
1
1989
1855
0.010
Why?
Time Factors
1
1989
3182
0.010
Why?

Visualizations


Phatak's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department